Aurodox is a member of the family of kirromycin antibiotics, which inhibit protein biosynthesis by binding to elongation factor Tu (EF-Tu). We have determined the crystal structure of the 1:1:1 complex of Thermus thermophilus EF-Tu with GDP and aurodox to 2.0-Å resolution. During its catalytic cycle, EF-Tu adopts two strikingly different conformations depending on the nucleotide bound: the GDP form and the GTP form. In the present structure, a GTP complex-like conformation of EF-Tu is observed, although GDP is bound to the nucleotide-binding site. This is consistent with previous proposals that aurodox fixes EF-Tu on the ribosome by locking it in its GTP form. Binding of EF-Tu⅐GDP to aminoacyl-tRNA and mutually exclusive binding of kirromycin and elongation factor Ts to EF-Tu can be explained on the basis of the structure. For many previously observed mutations that provide resistance to kirromycin, it can now be understood how they prevent interaction with the antibiotic. An unexpected feature of the structure is the reorientation of the His-85 side chain toward the nucleotide-binding site. We propose that this residue stabilizes the transition state of GTP hydrolysis, explaining the acceleration of the reaction by kirromycin-type antibiotics.
Aurodox, an antibiotic excreted by Streptomyces goldiniensis, is the N-methyl derivative of kirromycin (occasionally also named mocimycin), which is the prototype of a large family of antimicrobial agents (1, 2) . In all aspects investigated, aurodox ( Fig. 1) shows identical effects to the more thoroughly studied kirromycin (3). These antibiotics have been shown to interfere with the role of bacterial elongation factor Tu (EF-Tu) 1 in protein biosynthesis (4) . EF-Tu is a vital component of the protein biosynthesis machinery. In its active GTP complex, the 44-kDa protein binds aminoacyl-tRNA (aa-tRNA) and delivers it to the A site of the messenger RNA-programmed ribosome.
Upon codon/anticodon interaction, GTP is hydrolyzed, leading to a major conformational change of EF-Tu (5) (6) (7) (8) . This in turn triggers the subsequent release of EF-Tu⅐GDP from the ribosome. Fast regeneration of active EF-Tu⅐GTP from the inactive GDP form requires catalysis by the nucleotide exchange factor EF-Ts.
Kirromycin interrupts the functional cycle of EF-Tu by inhibiting the release of the EF-Tu⅐GDP complex from the ribosome. The resulting stalled ribosome causes a polysomal traffic jam on the mRNA. In accordance with this mechanism, kirromycin sensitivity is dominant over kirromycin resistance. The disability of EF-Tu⅐GDP to dissociate from the ribosome in the presence of kirromycin is due to the formation of a quaternary complex with aa-tRNA and the antibiotic (1, 9) . In agreement with this, it has been shown in vitro that EF-Tu⅐GDP has significant affinity (K d ϭ 10 M) for aa-tRNA in the presence but not in the absence of kirromycin (10) . A possible explanation for this could be that in this complex, the EF-Tu adopts a conformation similar to its GTP form even when bound to GDP (11) . Supporting evidence for this idea is provided by the electrophoretic behavior (12) and by sensitivity toward proteolytic cleavage (11) .
Further activities of kirromycin (1) are (i) stimulation of the intrinsic GTPase activity of EF-Tu, (ii) decrease (by 3 orders of magnitude) of aa-tRNA binding to EF-Tu⅐GTP, (iii) inhibition of EF-Ts binding, (iv) increase of the EF-Tu nucleotide exchange rate for GDP (while affinity is largely unchanged), (v) increase of the affinity of EF-Tu for GTP by a factor of at least 100, and (vi) prevention of phosphorylation of EF-Tu (13) . No crystal structure of an EF-Tu complex with kirromycin has been published to date, although crystals of a quaternary complex EF-Tu⅐GppNHp⅐Phe-tRNA Phe ⅐kirromycin diffracting to ϳ3.5 Å have been reported (14) . The crystal structure of a complex between EF-Tu⅐GDP and GE2270A, an antibiotic unrelated to kirromycin, has been published recently (15) .
Here we present the crystal structure of the 1:1:1 complex of Thermus thermophilus EF-Tu with GDP and aurodox at 2.0-Å resolution. The EF-Tu from this organism shares 82% sequence identity with the protein from Escherichia coli and has been shown to be similarly sensitive to kirromycin (16) . The crystal structure presented here nicely explains the mutations reported to confer resistance to EF-Tu against the antibiotic (17) (18) (19) (20) .
EXPERIMENTAL PROCEDURES
Preparation of the Ternary Complex EF-Tu⅐GDP⅐Aurodox-Since aurodox was reported to be moderately sensitive to light (21) , exposure was kept at a minimum. Because of its extremely low solubility in water, a 120 mM alcoholic solution was prepared. T. thermophilus EF-Tu was overexpressed and purified as a GDP complex as previously described (22) . The protein was then dialyzed into buffer (20 mM sodium * This work was funded in part by the Federal Ministry of Education and Research, through Deutsches Elektronen-Synchrotron-HS Grant 05SH8BJA, and by Deutsche Forschungsgemeinschaft Grant Hi611/ 1-3. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The 1 The abbreviations used are: EF-Tu, elongation factor Tu; EF-Ts, elongation factor Ts; r.m.s., root mean square; GppNHp, ␤,␥-imidoguanosine 5Ј-triphosphate; aa-tRNA, aminoacyl transfer RNA.
cacodylate, pH 7.0, 100 mM ammonium sulfate, 5 mM magnesium sulfate, 20 M GDP) and concentrated to 9 -12 mg/ml by ultrafiltration. The EF-Tu⅐GDP⅐aurodox complex was prepared by adding aurodox at a 5-7-fold molar excess to the protein solution, followed by incubation overnight. A minor precipitate was removed by centrifugation before crystallization set-ups were prepared. Nearly complete formation of the EF-Tu⅐GDP⅐aurodox complex was verified by native gel electrophoresis. As described by Mesters et al. (17) , the EF-Tu⅐GDP⅐aurodox complex showed a clear band shift compared with the aurodox-free EF-Tu⅐GDP. Chemicals used were obtained from Sigma or Merck in pro analysi quality.
Crystallization-Crystals of EF-Tu⅐GDP⅐aurodox were grown using the hanging drop vapor diffusion method. 2-4 l of solution of this ternary complex were mixed with the same amount of reservoir solution (50 mM Tris, 200 mM sodium acetate, 23-25% polyethylene glycol 4000, final pH 7.8 -9.0). Within 10 days in the dark at 19°C, platelet-like crystals grew to a maximum size of 450 ϫ 250 ϫ 60 m. Purification of the complex by gel filtration (Superdex 200 HR 10/30; Amersham Pharmacia Biotech) prior to crystallization did not improve the crystal quality.
Collection of Diffraction Data-Crystals were removed from the crystallization droplet with a nylon loop and immediately flash-cooled in a 100 K nitrogen stream generated by an Oxford Cryostream cooling system (Oxford Cryosystems, Oxford, United Kingdom). No further cryoprotectant was needed in addition to the polyethylene glycol in the mother liquor. Diffraction data were initially collected using an FR591 rotating copper anode x-ray generator (Nonius, Delft, The Netherlands) equipped with a 30-cm Mar Research image plate (X-ray Research, Hamburg, Germany). Data extending to 2.6 Å were collected over a crystal rotation range of 124°in two batches, as recommended by the program STRATEGY (23) . A full data set to 2.0-Å resolution was subsequently collected using the Joint IMB Jena-University of Hamburg-EMBL synchrotron beamline X13 at Deutsches Elektronen-Synchrotron, Hamburg, at a wavelength of 0.913 Å. Diffraction intensities were recorded using a Mar Research CCD detector (X-ray Research, Hamburg, Germany). Data collection parameters are given in Table I .
Data Processing, Structure Solution, and Refinement-Diffraction data were indexed, integrated, and scaled using the HKL package (24) . TRUNCATE (25) was used to derive structure amplitudes from the measured intensities. The space group was determined to be P2 1 , with unit cell dimensions a ϭ 69.13 Å, b ϭ 101.00 Å, c ϭ 79.15 Å, ␤ ϭ 113.47°. This unit cell has not been observed before for any EF-Tu crystal. The asymmetric unit was assumed to contain two ternary complexes, corresponding to a packing density of 2.9 Å 3 /Da and a solvent content of ϳ58% (26) .
Using the diffraction data collected with CuK␣ radiation, molecular replacement was carried out using the program AMoRe (27) . Based on the assumption that in the aurodox complex, a new EF-Tu conformation could exist as the consequence of a reorientation of domain 1 relative to the other two domains, domain 1 and domain 2/3 were treated as independent search molecules. In two different runs, the domains were taken from the structures of either Thermus aquaticus EF-Tu⅐GDP (8) or T. thermophilus EF-Tu⅐GppNHp (5), 2 leading to equivalent solutions (R ϭ 0.420 and 0.431, correlation coefficient 0.520 and 0.547, respectively, for the resolution range between 15.0 and 3.5 Å). The correctness of the solution was indicated by the equivalent arrangement of domain 1 and domain 2/3 in both noncrystallographic copies of the complex in the asymmetric unit. Furthermore, the C terminus of domain 1 was close to the N terminus of domain 2/3.
Although the two structural models obtained by the described molecular replacement approach were very similar, they were initially refined independently using CNS (28) . 5% of the unique reflections were set aside for the calculation of R free (29) . After a first round of rigid body refinement, simulated annealing, and energy minimization in torsion angle space, the R free values at 3.2-Å resolution for the starting models derived from the GDP and GTP forms could be reduced to 0.372 and 0.354, respectively. Thereafter, refinement was continued with the model derived from the T. thermophilus EF-Tu⅐GppNHp complex only. At this stage of refinement, the linker between the C terminus of domain 1 and the N terminus of domain 2/3 could be modeled into the electron density. There was no clear density, however, for residues 39 -66, which were therefore removed from the model at this stage. In comparison with the structure of EF-Tu⅐GppNHp (5), 2 the conformations of several side chains had to be altered, most notably that of Arg-124 (residue numbering is according to T. thermophilus EF-Tu). After this first round of refinement, the R free dropped to 0.335, and the densities for the GDP and aurodox molecules were very clear.
The program Hyperchem (Hypercube Inc., Waterloo, Canada) was employed to build an initial atomic model for aurodox, which was then fitted into an F o Ϫ F c difference density map (contoured at 2.5 above the mean), using the program O (30). This step improved the R free to 0.305. Topology and parameter files for the antibiotic were generated with help of the program HIC-UP (31). Noncrystallographic symmetry restraints used for the first rounds of refinement were later removed, and refinement was continued against the synchrotron data that had become available in the meantime. The R and R free of the final structural model are 0.191 and 0.222, respectively, for all data between 20.0-and 2.0-Å resolution. Refinement statistics are given in Table I .
For construction of several models for analyzing possible changes in EF-Tu⅐GDP or EF-Tu⅐GppNHp upon docking aurodox to its binding site, ALIGN (32) was used to superimpose the domains. For characterization of rigid body movements of domains (Table II) , domains 1 of the pair of EF-Tu models to be compared were first superimposed (32) . Then the rotation angle was calculated from the superposition operator of the analyzed elements.
RESULTS AND DISCUSSION
Crystallization-Crystals of the EF-Tu⅐GDP⅐aurodox complex could be readily and reproducibly obtained following the procedure described under "Experimental Procedures." Washed and dissolved crystals showed only one band on native polyacrylamide gels, with an unambiguous shift compared with EF-Tu⅐GDP, proving that all EF-Tu in the crystal was in complex with aurodox (data not shown).
Structure Elucidation and Model Quality-The structure of the complex was solved by molecular replacement (27) . Initial trials using the complete EF-Tu molecule as a search model failed, irrespective of whether the GTP or GDP form of the protein (5, 8) was used. On the other hand, both forms lead to the correct solution when domains 1 and 2/3 were used as two separate search models. Using synchrotron radiation data, the model was refined to 2.0-Å resolution (Table I) . Electron density for the aurodox molecule is shown in Fig. 2 water molecules. Residues 1 and 2 of each molecule, residues 53-64 in molecule A, and residues 42-65 in molecule B have been omitted in the model due to poor or missing electron density. Since the region 42-65, the so-called effector region of EF-Tu, is often subject to spontaneous proteolysis (33), SDSpolyacrylamide gels were used to prove that the protein was not cleaved in our crystals (data not shown). Therefore, we have to assume that this region is not visible in the electron density maps due to its high mobility.
The Overall Structure-To appreciate the uniqueness of the structure presented in this paper, a brief overview of the known structures and forms of EF-Tu is needed here. The protein folds into three clearly distinct domains (5, 6) . Domain 1 (residues 7-210) is composed of a predominantly parallel six-stranded ␤-sheet surrounded by ␣-helices. It contains the guanine nucleotide-binding site (hence, it is also called the "G domain"). Two segments of the polypeptide chain, switch I (residues 50 -64) and switch II (residues 83-99), act as sensors for the presence or absence of GTP and transmit this signal into the other two domains (5, 7). In the GTP form, switch I forms an ␣-helix, which unfolds to a ␤-hairpin in the GDP complex (7, 8) . Concomitantly, the switch II helix changes both its orientation and length upon GTP hydrolysis (5, 7). Domain 2 (residues 212-310) and domain 3 (residues 311-405) are ␤-barrels of seven and six antiparallel ␤-strands, respectively, that share an extended interface. Characteristic for each of the known EF-Tu structures is the relative arrangement of domains 2/3 to domain 1. So far, in all known complexes with GTP analogues, the EF-Tu exists in a compact form with tight interfaces between domains 1 and 2 as well as 1 and 3 ( Fig. 3A (5) ). This conformation is also seen in the ternary complexes of EF-Tu⅐GppNHp with aa-tRNAs (34, 35) . In contrast, in all GDP complex structures determined so far, a large hole opens between domains 1 and 2, making the molecule much less compact (Fig. 3C (7, 8,  33) ).
Certainly, the most striking feature of the ternary complex between EF-Tu⅐GDP and aurodox presented here (Fig. 3B) is its overall similarity to that of the binary complex EFTu⅐GppNHp, the active conformation of EF-Tu (Fig. 3A) . The current structure supports the proposal that kirromycin induces a conformation of EF-Tu⅐GDP that is similar to the GTP form, thus preventing its release from the ribosome after and despite hydrolysis of GTP to GDP and P i . Aurodox binds to the interface between domains 1 and 3 (Fig. 3B) . To accommodate the antibiotic in this binding site, domains 2 and 3 are rotated by about 9.7 and 15.4°, respectively (averaged values for molecules A and B), relative to their position in the GppNHp form (5) . 2 This rotation implies a small but unambiguous movement of domain 3 with respect to domain 2. The C␣ r.m.s. deviation values between EF-Tu⅐GDP⅐aurodox and either EFTu⅐GppNHp (5) 2 or EF-Tu⅐GDP (8) are listed in Table II . To force EF-Tu⅐GDP into this GTP complex-like conformation, the antibiotic has to provide more favorable interactions between itself and domains 1 and 3 than these domains alone would have in the GDP complex. This is achieved by strong interactions of the antibiotic with both domains 1 and 3, effectively gluing them together (see Figs. 3 and 4 and Table III) .
Another feature that emphasizes the overall strategy of the antibiotic of coercing the GDP-bound form into a GTP complexlike conformation is the rearrangement of switch II into an intermediate form, which, however, is more similar to the conformation found in the GTP form. Nevertheless, there are important deviations, such as a different positioning of the thoroughly scrutinized residue His-85 (36); in addition to a somewhat different conformation of the main chain, the conformation over the C␣-C␤ bond of the side chain is synclinal in the EF-Tu⅐GDP⅐aurodox complex but antiperiplanar in the GppNHp complex (Ϫ44 and Ϫ164°, respectively, for 1 ). This change brings the His-85 side chain close to the nucleotidebinding site (see Fig. 5 ). The implications of this are discussed below, in context of the GTPase activity.
Only very weak electron density was observed for residues 42-52, and no density was observed for residues 53-64 (switch I). Based on the structure of EF-Tu⅐GppNHp (5), 2 residues 42-52 were modeled into molecule A, but nevertheless they retain poor electron density after refinement. Both the ␣-helical conformation of switch I as seen in EF-Tu⅐GppNHp and the ␤-hairpin conformation observed in EF-Tu⅐GDP would be compatible with the structure of the protein in the aurodox complex. However, in both copies in the asymmetric unit, the electron density for Thr-65 and Ala-66 clearly indicates that 
, where index hkl sums over all reflections and i sums over all equivalent and symmetry-related reflections (45) .
c R rim is the redundancy-independent merging R-factor (46), which is identical to R meas of Diederichs and Karplus (47) .
with N being the number of times a given reflection has been observed.
d R pim is the precision-indicating merging R-factor (46) .
. e 72 atoms were modeled into alternate sites.
FIG. 2. The final model of aurodox in the 2F
o ؊ F c electron density map contoured at 1 . Two of the residues (Tyr-161, Leu-121) in the vicinity of the pyridone ring are also shown. these residues deviate from the conformations found in either the GppNHp or the GDP form. Therefore, switch I appears to have a new, highly mobile conformation in the aurodox complex.
Nucleotide Binding and Hydrolysis-The K d for GTP decreases more than 100-fold upon aurodox binding (37) , which is most probably due to stabilization of the GTP complex-like structure of EF-Tu induced by the antibiotic. Kirromycin has also been shown to increase the intrinsic GTPase rate of EF-Tu by 1 order of magnitude (1) . In the present structure, the electron density for the nucleotide, GDP, is clear, indicating full occupancy. The binding mode of GDP is the same as in the binary EF-Tu⅐GDP complex (7, 8, 38) , although the high flexibility of the effector region (including switch I) in the current structure appears to preclude the existence of strong interactions between Tyr-47 OH and the ␣-phosphate or between Asp-51 and the magnesium ion (via water). The side chains of residues 47 and 51 (as modeled in molecule A) are only partially visible in the electron density. The weakening of the Asp-51/Wat/Mg 2ϩ interaction could very well explain the observed increase of the GDP exchange rate (37), analogous to the EF-Ts action on EF-Tu⅐GDP by which the Asp-81/Wat/Mg 2ϩ interaction, among others, is perturbed. The nearly perfect octahedral coordination of the Mg 2ϩ ion in the current structure is largely identical to the one seen in the binary EFTu⅐GDP complex (7, 38) . The metal is in contact with the hydroxyl group of Thr-25, the ␤-phosphate, and four water molecules.
Switch II (residues 83-99) of EF-Tu is known to display considerable conformational variability, depending on whether GTP, GDP, or EF-Ts is bound. In the aurodox complex, we find yet another conformation for this segment (Fig. 5) . The trigger for the conformational changes is the peptide between Pro-83 and Gly-84. With GppNHp bound, Gly-84 N hydrogen-bonds the ␥-phosphate. In both structures with bound GDP (EFTu⅐GDP and EF-Tu⅐GDP⅐aurodox), the peptide between Pro-83 and Gly-84 is flipped relative to the GTP form, and the carbonyl group points toward the empty ␥-phosphate position. When GTP is bound to the aurodox complex, we would expect the peptide 83-84 to flip back in order to avoid steric and electrostatic repulsion between the carbonyl of Pro-83 and the ␥-phosphate.
In the structure of EF-Tu⅐GppNHp, the ␥-phosphate of the nucleotide as well as the "nucleophilic water" (which is responsible for the attack on the ␥-phosphorus atom during GTP hydrolysis; see Berchtold et al. (5) ) are shielded from bulk solvent by a hydrophobic gate consisting of the side chains of Val-20 and Ile-61. Berchtold et al. (5) have proposed that in the ribosome-mediated GTPase reaction, one or both wings of the hydrophobic gate could open, providing access to the ␥-phosphate for His-85 and partly explaining the acceleration of the GTP hydrolysis rate on the programmed ribosome. In the ternary EF-Tu⅐GDP⅐aurodox complex described here, Ile-61 is disordered, along with the entire switch I. The observed effect on His-85 is the same as proposed for ribosome binding of EFTu⅐GTP. Concomitant with the opening of the hydrophobic gate, an altered orientation of His-85 is observed. This side chain is now oriented toward the nucleotide-binding site and could easily contact the ␥-phosphate when present (Fig. 5) . Thus, its role could be similar to that of Gln-61 in the   FIG. 3. Tertiary structure of EF-Tu. A, EF-Tu from T. thermophilus with GppNHp bound (GTP form).
2 B, EF-Tu from T. thermophilus with GDP and aurodox bound (aurodox form; this work). C, EF-Tu from T. aquaticus with GDP bound (GDP form (8) ). The G domains (top) have been superimposed to obtain the same orientation. Domains 2 (bottom left) and 3 (bottom right) exhibit major movements. Switch I is shown in orange. The nucleotides, magnesium ion, and aurodox are shown as ball-and-stick models. These images have been created with Molscript (48), Bobscript (49) , and Render3D (50). (5) 2 or EF-Tu ⅐ GDP (8) The numbers for molecules A and B are given separately for each combination. The values in parentheses show the number of C␣ atoms used in the alignment after rejection of outliers (32) . The rotation angles of domains 2, 3, and 2/3 are also given, based on an alignment of domains 1. Ras⅐GDP⅐AlF 3 -GAP complex (39) (i.e. stabilization of the transition state). However, the acceleration of the GTP hydrolysis rate by aurodox is only ϳ10-fold rather than 10 5 -fold as in the Ras⅐GAP complex, because a residue analogous to the so-called arginine finger (Arg-789 of GAP) is not present in EF-Tu⅐GTP⅐aurodox.
Binding Site of Aurodox-Clear density was also seen for the antibiotic (Fig. 2) . It fits perfectly into its binding site at the interface of domains 1 and 3. This site shows no overlap with the one for the unrelated antibiotic GE2270A (15) , in agreement with the observation that EF-Tu can bind both kirromycin and GE2270A simultaneously (40) . The overall location of the aurodox binding site has been predicted by us previously, on the basis of the location of resistance mutations (17) . A schematic drawing of aurodox in its binding site is shown in Fig. 4 . The three ring systems of aurodox, namely the pyridone, the tetrahydrofuran, and the goldinoic acid, are arranged in an extended way with the aliphatic tail attached to the goldinoic acid bending backwards. Hydrophobic contacts clearly dominate over hydrophilic ones, especially at the goldinoic acid end of aurodox. The pyridone and the tetrahydrofuran rings bind to domain 1, and the aliphatic tail on the goldinoic acid is embedded in a pocket formed by the hydrophobic faces of the following residues from both domains 1 and 3: Ile-93, Gln-125, Tyr-343, Ala-387, Arg-389, and Thr-394. The hydrophobic linker between the goldinoic acid and the tetrahydrofuran ring interacts with Leu-323, Thr-394, and Gln-125. The third hydrophobic part, the linker between the tetrahydrofuran ring and the pyridone ring, is in contact with Leu-121, Tyr-161, and Glu-327. Hydrogen bonds are formed between the side chain of Tyr-161 and the hydroxyl group of the pyridone ring and between its main-chain oxygen and one of the hydroxyl groups of the tetrahydrofuran ring. The other hydroxyl group hydrogenbonds to the Arg-124 guanidinium group. The amide nitrogen of aurodox hydrogen-bonds to the main-chain oxygen of Gln-125. Most other heteroatoms make hydrogen bonds to the protein via water molecules (see Table III) , with the weakest interactions made by the goldinoic acid oxygens.
Inspection of the known structures of EF-Tu⅐GDP and EFTu⅐GppNHp shows that neither has the binding crevice for aurodox preformed. The domain 1-3 interface is very different in the GppNHp and in the GDP complexes (5-8), and in both structures, it has to be opened and rearranged to accommodate the antibiotic. Thus, aurodox binds by ligand-induced fit rather than by a lock-and-key mechanism.
Resistance Mutations in EF-Tu and Phosphorylation of Thr-394 -Kirromycin resistance mutations have so far only been studied with elongation factors Tu from E. coli and Salmonella typhimurium (17) (18) (19) (20) . Due to the absolute conservation of the affected residues and the high structural similarity between E. coli and T. thermophilus EF-Tu, observations made with the present structure should also apply to the homologous proteins. The methyl group that distinguishes aurodox from kirromycin does not make any contacts (shorter than 4.4 Å) to the protein. This agrees with the observation that kinetic data show no evident differences between the two compounds (3).
The structure of the aurodox complex with EF-Tu⅐GDP allows us to explain several previously published (17) (18) (19) (20) resistance mutations. A good example is the mutation of Tyr-161 to Asp, Asn, or Cys. This would abolish a strong hydrogen bond (2.6 Å) from the pyridone ring to the tyrosine side chain as well as hydrophobic interactions between the aromatic ring and the linker between the tetrahydrofuran and pyridone rings (Fig. 4) . At the other side of this hydrophobic linker, a second resistance mutation, L121Q, has been observed (18) . A glutamine would not only prevent the hydrophobic interaction but also introduce steric clashes. Another telling observation is the clustering of resistance mutations around the hydrophobic pocket accommodating the aliphatic extension of the goldinoic acid moiety of aurodox (Fig.  4) . Mutation of Gln-125 to long charged side chains (Arg, Lys, Glu) was reported to confer the most pronounced resistance (17) . This is readily explained by the fact that these charged side chains would be close enough to the binding pocket to severely perturb its highly hydrophobic character and thereby the binding of the antibiotic. Another nearby resistance mutation, A387T/V/S (A387T (19) , A387V (20) , A387S (18)), would sterically interfere with binding of the aliphatic extension of the goldinoic acid in its hydrophobic pocket. With distances between 3.1 and 4.1 Å to atoms of this aliphatic tail, even mutations to the relatively short side chains mentioned above would prevent the antibiotic from binding.
A further resistance mutation that can be explained by a resulting steric clash is that of Gly-328 to Asp. The C␣ atom of the wild-type glycine has distances of 3.9 -4.1 Å to atoms of the pyridone ring, leaving no space for any but the smallest side chains. Other residues listed in Table III are good candidates for further resistance mutations. The mutational space is limited, however, by restrictions set up by the functionality of the domain 1/3 interface.
In addition to these mutations, it has been reported that in E. coli EF-Tu, phosphorylation of Thr-382 (Thr-394 in T. thermophilus EF-Tu) prevents kirromycin from binding to the protein (13). Our structure shows that this is due to the fact that a highly charged phosphate group on this residue would, like the mutation of Gln-125 to Lys, destroy the hydrophobic pocket for the aliphatic extension of the goldinoic acid.
Although located within 15 Å of the binding site, three other previously published resistance mutations (Q341H, ⌬(I310), and E390K (18)) and the cross-linking of kirromycin to Lys-357 (41) cannot be explained on the basis of direct interactions evident from our structure. Residue 310 resides within the linker between domains 2 and 3. Its deletion might interfere with the slight mutual rearrangement of domains 2 and 3 observed in the aurodox complex, thus preventing strong binding of the antibiotic. Mutations of Gln-341 and Glu-390, which are involved in aa-tRNA binding (34, 35) will decrease the affinity of EF-Tu⅐GppNHp/EF-Tu⅐GDP⅐aurodox for aa-tRNA such that EF-Tu⅐GDP⅐aurodox cannot create a polysomal traffic jam. EF-Tu⅐GDP complexes of various mutants were reported to be more resistant to kirromycin than the corresponding EFTu⅐GTP complexes (17) . As an explanation, resistant variants of EF-Tu were postulated to display two lines of defense against antibiotic binding: one before and one after GTP hydrolysis. With the current structure at hand, we can elaborate on the latter idea a bit further. Since the conformation of EF-Tu in its GTP form is much more similar to EF-Tu⅐GDP⅐aurodox than is the binary GDP complex, less than perfect binding of the antibiotic may be sufficient to support the small conformational changes required. On the other hand, when starting from the binary GDP complex, ideal interaction between the antibiotic and EF-Tu is required to drive the accompanying huge conformational change. Therefore, kirromycin can still bind to some resistance mutants such as G328D in their GTP but not their GDP form; i.e. the defense against binding the antibiotic becomes apparent only after GTP hydrolysis on the ribosome (17) . The most resistant variants of EF-Tu, A375T and Q124K, already perturb aurodox binding to the GTP form (17) . If this first line of defense breaks down at very high antibiotic concentrations, aurodox will be evicted after GTP hydrolysis, as a second line of defense.
Mutually Exclusive Binding of EF-Ts and Aurodox-It has long been known that binding of kirromycin and of the nucleotide exchange factor EF-Ts to EF-Tu are mutually exclusive (2) . Based on our EF-Tu⅐GDP⅐aurodox structure and that of EF-Tu⅐EF-Ts (42, 43), we point out several structural features for an explanation. Phe-82 of EF-Ts is critical in the EF-Tu/ EF-Ts interaction. It inserts between His-85 and His-119, which are hydrogen-bonded to one another in the GDP form. In the aurodox complex, this latter interaction is replaced by a hydrogen bond between His-119 and the main-chain oxygen of Gly-84 instead. As a consequence, the His-His pair is no longer available as a recognition target for EF-Ts. Furthermore, EFTu⅐GDP⅐aurodox with its GTP-like conformation gives a poor binding partner for EF-Ts, which preferentially binds to domains 1 and 3 in an arrangement as seen in the EF-Tu⅐GDP complex. Vice versa, since the domains 1 and 3 are firmly locked in the EF-Tu⅐EF-Ts complex, aurodox cannot induce the conformational changes required for its own binding and will fail to evict EF-Ts from the complex.
aa-tRNA Binding-One of the most important effects induced by the antibiotic is the ability of EF-Tu⅐GDP⅐aurodox (and even nucleotide-free EF-Tu⅐aurodox) to bind aa-tRNA (44), a property normally associated with EF-Tu⅐GTP. In both EF-Tu⅐GppNHp⅐aa-tRNA complex structures determined so far (34, 35) , the conformation of the protein is very similar to that in the GppNHp complex (5), with the most prominent deviations occurring in switch I (residues 53-64). Obviously, EFTu⅐GDP⅐aurodox can bind aa-tRNA because the protein adopts a GTP-like conformation. r.m.s. deviation values for C␣ atoms in domains 1-3 between EF-Tu⅐GDP⅐aurodox and EFTu⅐GppNHp⅐Phe-tRNA Phe are only ϳ0.6 Å each. Although aurodox increases the affinity of EF-Tu⅐GDP for aa-tRNA, it de- creases it in case of EF-Tu⅐GTP by about 3 orders of magnitude (10) . The disorder of switch I in the aurodox complex disturbs the interaction between G1 of the aa-tRNA and Asn-64. Together with the somewhat different orientations of domains 2 and 3, this could contribute to the decreased affinity for aa-tRNA.
To conclude, the effect of kirromycin on EF-Tu can thus be explained in general terms by the GTP complex-like form the protein is forced to adopt and, in more detail, by the specific residues that are in contact with the antibiotic and the nucleotide.
